journal article·2024-04

Electrospun nanofibers combined with Fe-doped mesoporous bioactive glass nanoparticles induce in vitro melanoma cell death

Khatereh Sadeqzadeh, Simin Nazarnezhad, Farzad Kermani, Zoleikha Azari, Kobra Foroughi, Sahar Mollazadeh, Alireza Ebrahimzadeh-Bideskan, Reyhaneh Shafieian, Alireza Sadeghi-Avalshahr, Ahmed El-Fiqi, Saeid Kargozar

Ceramics International· Volume 50· Issue 7
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Laser-Ablation Synthesis of Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Recent advances in nanotechnology for the treatment of melanoma10.3390/molecules26040785 ↗
2. Epidemiology of melanoma
3. Global burden of cutaneous melanoma in 2020 and projections to 204010.1001/jamadermatol.2022.0160 ↗
4. How to treat melanoma? The current status of innovative nanotechnological strategies and the role of minimally invasive approaches like ptt and pdt10.3390/pharmaceutics14091817 ↗
5. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility10.1038/s41588-020-0611-8 ↗
6. Many ways to resistance: how melanoma cells evade targeted therapies10.1016/j.bbcan.2019.02.002 ↗
7. A NIR-II light-modulated injectable self-healing hydrogel for synergistic photothermal/chemodynamic/chemo-therapy of melanoma and wound healing promotion10.1039/D2TB00923D ↗
8. Electrospun fibrous architectures for drug delivery, tissue engineering and cancer therapy10.1002/adfm.201802852 ↗
9. Latest progress in electrospun nanofibers for wound healing applications10.1021/acsabm.8b00637 ↗
10. Gelatin-polycaprolactone-nanohydroxyapatite electrospun nanocomposite scaffold for bone tissue engineering10.1016/j.msec.2020.111588 ↗
11. Crosslinking of the electrospun gelatin nanofibers10.1016/j.polymer.2006.02.046 ↗
12. Fabrication and characterization of PVA/CS-PCL/gel multi-scale electrospun scaffold: simulating extracellular matrix for enhanced cellular infiltration and proliferation10.1080/09205063.2020.1714534 ↗
13. Bioactive glasses for soft and hard tissue healing applications—a short review10.3390/app13106151 ↗
14. Bioactive materials for soft tissue repair10.3389/fbioe.2021.613787 ↗
15. Pectin-reinforced electrospun nanofibers: fabrication and characterization of highly biocompatible mats for wound healing applications
16. Free radicals for cancer theranostics10.1016/j.biomaterials.2020.120474 ↗
17. Improved osteogenesis and angiogenesis of theranostic ions doped calcium phosphates (CaPs) by a simple surface treatment process: a state-of-the-art study10.1016/j.msec.2021.112082 ↗
18. Iron (Fe)-doped mesoporous 45S5 bioactive glasses: implications for cancer therapy10.1016/j.tranon.2022.101397 ↗
19. Preparation and characterization of platelet lysate (Pl)-Loaded electrospun nanofibers for epidermal wound healing10.1016/j.xphs.2022.04.008 ↗
20. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers10.1038/s41589-020-0613-y ↗
21. Radiation-Induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers10.1021/acschembio.9b00939 ↗
22. In vitro study of the recruitment and expansion of mesenchymal stem cells at the interface of a Cu-doped PCL-bioglass scaffold10.3390/biomimetics7010019 ↗
23. Poly(epsilon-caprolactone)/bioactive glass composite electrospun fibers for tissue engineering applications10.1002/jbm.a.37578 ↗
24. A critical review of bioactive glasses and glass–ceramics in cancer therapy10.1111/ijag.16601 ↗
25. Electrospinning for tissue engineering applications10.1016/j.pmatsci.2020.100721 ↗
26. Processing and characterization of aligned electrospun gelatin/polycaprolactone nanofiber mats incorporating borate glass (13-93B3) microparticles10.1088/1748-605X/acf0ad ↗
27. Effect of citric acid on swelling resistance and physicochemical properties of post-crosslinked electrospun polyvinyl alcohol fibrous membrane
28. Fe-MIL-101 exhibits selective cytotoxicity and inhibition of angiogenesis in ovarian cancer cells via downregulation of MMP
29. The cytotoxicity of dextran-coated iron oxide nanoparticles on Hela and MCF-7 cancerous cell lines10.29252/arakmu.11.5.31 ↗
30. Bioactive glasses-reinforced human amniotic membrane for tissue engineering applications10.1016/j.matlet.2023.135786 ↗
31. Fabrication and characterization of cobalt- and copper-doped mesoporous borate bioactive glasses for potential applications in tissue engineering10.1016/j.ceramint.2023.09.214 ↗
32. Iron oxide/salicylic acid nanoparticles as potential therapy for B16F10 melanoma transplanted on the chick chorioallantoic membrane10.3390/pr8060706 ↗
33. Electrospinning of Fe-doped ZnO nanoparticles incorporated polyvinyl alcohol nanofibers for its antibacterial treatment and cytotoxic studies10.1016/j.eurpolymj.2019.05.038 ↗
34. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)10.3402/nano.v1i0.5358 ↗
35. Effects of iron or manganese doping of ZnO nanoparticles on their dissolution, ROS generation and cytotoxicity10.1039/C4RA02481H ↗
36. Signaling pathways and defense mechanisms of ferroptosis10.1111/febs.16059 ↗
37. Bioactive metal-containing nanomaterials for ferroptotic cancer therapy10.1039/D0TB02138E ↗
38. Wet chemical mediated hematite α-Fe2O3 nanoparticles synthesis: preparation, characterization and anticancer activity against human metastatic ovarian cancer10.1016/j.jallcom.2020.155118 ↗
39. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
40. Transcriptome investigation and in vitro verification of curcumin-induced HO-1 as a feature of ferroptosis in breast cancer cells
41. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation10.1016/j.bbrc.2016.08.034 ↗